Luca Zammataro Selected Research

Squamous Cell Carcinoma (Epidermoid Carcinoma)

11/2019

Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luca Zammataro Research Topics

Disease

30	Neoplasms (Cancer) 01/2022 - 02/2010
8	Carcinoma (Carcinomatosis) 11/2021 - 10/2016
8	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2017
4	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 01/2017
4	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2010
3	Carcinosarcoma 02/2020 - 10/2016
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020 - 10/2019
3	Inflammation (Inflammations) 01/2018 - 02/2010
3	Ovarian Epithelial Carcinoma 10/2017 - 01/2017
2	Triple Negative Breast Neoplasms 01/2021 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2018
2	Adenocarcinoma 01/2020 - 11/2019
2	Pneumonia (Pneumonitis) 08/2018 - 01/2018
1	Turcot syndrome 01/2022
1	Microsatellite Instability 01/2022
1	Melanoma (Melanoma, Malignant) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2019
1	Hemorrhage 01/2019
1	Fibrosis (Cirrhosis) 01/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018
1	Uterine Neoplasms (Uterine Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

8	Immunoconjugates (Immunoconjugate)IBA 11/2021 - 01/2017
5	sacituzumab govitecanIBA 02/2020 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2010
3	Surface Antigens (Surface Antigen)IBA 01/2020 - 01/2020
3	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2020 - 01/2020
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 01/2020
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
2	pembrolizumabIBA 01/2022 - 01/2018
2	pertuzumabIBA 11/2021 - 10/2017
2	Trastuzumab (Herceptin)FDA Link 11/2021 - 10/2017
2	Aurora Kinase AIBA 01/2021 - 01/2018
2	Formaldehyde (Formol)FDA Link 01/2020 - 01/2020
2	ParaffinIBA 01/2020 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 01/2019
2	neratinibIBA 11/2019 - 05/2017
2	AfatinibIBA 11/2019 - 01/2019
2	Chemokine ReceptorsIBA 01/2018 - 02/2010
2	ChemokinesIBA 01/2018 - 02/2010
2	trastuzumab duocarmazineIBA 10/2017 - 01/2017
2	DuocarmycinsIBA 10/2017 - 01/2017
2	Ado-Trastuzumab EmtansineIBA 10/2017 - 01/2017
1	NucleotidesIBA 01/2022
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	A-Form DNA (A-DNA)IBA 11/2021
1	DHES0815AIBA 11/2021
1	Alkylating AgentsIBA 11/2021
1	EpitopesIBA 11/2021
1	EnzymesIBA 01/2021
1	GlutaminaseIBA 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	linifanibIBA 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	Cytidine DeaminaseIBA 11/2019
1	copanlisibIBA 11/2019
1	olaparibIBA 10/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2019
1	Adenosine Diphosphate (ADP)IBA 10/2019
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 10/2019
1	CarcinogensIBA 08/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	binimetinibIBA 08/2018
1	SteroidsIBA 08/2018
1	Estrogen Receptor alphaIBA 01/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	MitogensIBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	Protein Kinases (Protein Kinase)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	CC ChemokinesIBA 01/2018
1	Notch ReceptorsIBA 01/2018
1	ClaudinsIBA 01/2018
1	Folate Receptor 1IBA 01/2018
1	mirvetuximab soravtansineIBA 01/2018
1	Monoclonal AntibodiesIBA 10/2017
1	PlatinumIBA 01/2017
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2017
1	cyclopentenyl cytosineIBA 01/2017
1	Diphtheria ToxinIBA 01/2017
1	Clostridium enterotoxinIBA 01/2017
1	Claudin-3IBA 01/2017
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2017
1	Programmed Cell Death 1 ReceptorIBA 01/2017
1	Nucleosomes (Nucleosome)IBA 10/2016
1	Histones (Histone)IBA 10/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2010
1	LigandsIBA 11/2010
1	Conditioned Culture MediaIBA 07/2010
1	factor AIBA 07/2010

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 11/2021 - 01/2017
5	Therapeutics 01/2021 - 02/2010
3	Intravenous Administration 02/2020 - 01/2020
1	Salvage Therapy 01/2018
1	Intraperitoneal Injections 01/2017